文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021.

作者信息

Zhou Xiao-Dong, Chen Qin-Fen, Yang Wah, Zuluaga Mauricio, Targher Giovanni, Byrne Christopher D, Valenti Luca, Luo Fei, Katsouras Christos S, Thaher Omar, Misra Anoop, Ataya Karim, Oviedo Rodolfo J, Pik-Shan Kong Alice, Alswat Khalid, Lonardo Amedeo, Wong Yu Jun, Abu-Abeid Adam, Al Momani Hazem, Ali Arshad, Molina Gabriel Alejandro, Szepietowski Olivia, Jumaev Nozim Adxamovich, Kızılkaya Mehmet Celal, Viveiros Octavio, Toro-Huamanchumo Carlos Jesus, Yen Kok Kenneth Yuh, Ospanov Oral, Abbas Syed Imran, Robertson Andrew Gerard, Fouad Yasser, Mantzoros Christos S, Zhang Huijie, Méndez-Sánchez Nahum, Sookoian Silvia, Chan Wah-Kheong, Treeprasertsuk Sombat, Adams Leon, Ocama Ponsiano, Ryan John D, Perera Nilanka, Sharara Ala I, Al-Busafi Said A, Opio Christopher Kenneth, Garcia Manuel, Lim-Loo Michelle Ching, Ruiz-Úcar Elena, Prasad Arun, Casajoana Anna, Abdelbaki Tamer N, Zheng Ming-Hua

机构信息

Department of Cardiovascular Medicine, the Heart Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Medical Care Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

出版信息

EClinicalMedicine. 2024 Sep 24;76:102848. doi: 10.1016/j.eclinm.2024.102848. eCollection 2024 Oct.


DOI:10.1016/j.eclinm.2024.102848
PMID:39386160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11462227/
Abstract

BACKGROUND: Obesity represents a major global health challenge with important clinical implications. Despite its recognized importance, the global disease burden attributable to high body mass index (BMI) remains less well understood. METHODS: We systematically analyzed global deaths and disability-adjusted life years (DALYs) attributable to high BMI using the methodology and analytical approaches of the Global Burden of Disease Study (GBD) 2021. High BMI was defined as a BMI over 25 kg/m for individuals aged ≥20 years. The Socio-Demographic Index (SDI) was used as a composite measure to assess the level of socio-economic development across different regions. Subgroup analyses considered age, sex, year, geographical location, and SDI. FINDINGS: From 1990 to 2021, the global deaths and DALYs attributable to high BMI increased more than 2.5-fold for females and males. However, the age-standardized death rates remained stable for females and increased by 15.0% for males. Similarly, the age-standardized DALY rates increased by 21.7% for females and 31.2% for males. In 2021, the six leading causes of high BMI-attributable DALYs were diabetes mellitus, ischemic heart disease, hypertensive heart disease, chronic kidney disease, low back pain and stroke. From 1990 to 2021, low-middle SDI countries exhibited the highest annual percentage changes in age-standardized DALY rates, whereas high SDI countries showed the lowest. INTERPRETATION: The worldwide health burden attributable to high BMI has grown significantly between 1990 and 2021. The increasing global rates of high BMI and the associated disease burden highlight the urgent need for regular surveillance and monitoring of BMI. FUNDING: National Natural Science Foundation of China and National Key R&D Program of China.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/ec149e0f32a1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/22b37a2fd7ba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/f8bbbe68a44d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/5bd1321f1598/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/e7205463c80a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/ec149e0f32a1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/22b37a2fd7ba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/f8bbbe68a44d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/5bd1321f1598/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/e7205463c80a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0366/11462227/ec149e0f32a1/gr5.jpg

相似文献

[1]
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021.

EClinicalMedicine. 2024-9-24

[2]
The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.

PLoS Med. 2020-7-28

[3]
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 2018-11-8

[4]
Global, regional, and national burden and trends of kidney cancer associated with high BMI from 1990 to 2021: Findings from the Global Burden of Disease Study 2021.

PLoS One. 2025-3-24

[5]
The global burden of disease attributable to high body mass index in 204 countries and territories: Findings from 1990 to 2019 and predictions to 2035.

Diabetes Obes Metab. 2024-9

[6]
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet. 2016-10-8

[7]
Burden of cancer attributable to high body mass index: A systematic analysis of the Global Burden of Disease Study 2021.

Clin Nutr. 2025-5

[8]
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[9]
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 2018-11-10

[10]
The burden of colorectal cancer attributable to diet low in whole grains from 1990 to 2021: a global, regional and national analysis.

Front Nutr. 2025-4-9

引用本文的文献

[1]
Global burden of hypertensive heart disease attributable to high body mass index from 1990 to 2021: a multidimensional analysis and public health response.

Front Cardiovasc Med. 2025-8-12

[2]
Global burden of cancer attributable to high BMI (1990-2031): a multidimensional analysis based on GBD and Mendelian randomization.

Front Nutr. 2025-8-5

[3]
AI-driven prediction of insulin resistance in non-diabetic populations using minimal invasive tests: comparing models and criteria.

Diabetol Metab Syndr. 2025-8-18

[4]
Independent and joint impacts of high body mass index and aging on global burden of chronic kidney disease: insights from the Global Burden of Disease Study 2021.

Front Nutr. 2025-7-25

[5]
Renal Function in Patients after Metabolic and Bariatric Surgery.

Obes Surg. 2025-8-9

[6]
Global burden and trends of high BMI-attributable chronic kidney disease: a comprehensive analysis from 1990 to 2021 and projections to 2035.

Front Nutr. 2025-7-22

[7]
Metabolic health and cardiovascular disease across BMI categories: NHANES findings.

J Health Popul Nutr. 2025-8-1

[8]
Advanced Proteomics Approaches Hold Potential for the Risk Assessment of Metabolism-Disrupting Chemicals as Omics-Based NAM: A Case Study Using the Phthalate Substitute DINCH.

Environ Sci Technol. 2025-8-12

[9]
The application and predictive value of the weight-adjusted-waist index in BC prevalence assessment: a comprehensive statistical and machine learning analysis using NHANES data.

BMC Cancer. 2025-7-29

[10]
Cost-Utility Analysis of Metabolic Bariatric Surgery for Individuals with Obesity in Saudi Arabia.

Clinicoecon Outcomes Res. 2025-7-23

本文引用的文献

[1]
Global burden of metabolic diseases, 1990-2021.

Metabolism. 2024-11

[2]
Current perspectives in obesity management: unraveling the impact of different therapy approach in real life obesity care.

J Transl Med. 2024-6-6

[3]
Body Roundness Index and All-Cause Mortality Among US Adults.

JAMA Netw Open. 2024-6-3

[4]
Outcomes of sugar reduction policies, United Kingdom of Great Britain and Northern Ireland.

Bull World Health Organ. 2024-6-1

[5]
Implementation of Obesity Science Into Clinical Practice: A Scientific Statement From the American Heart Association.

Circulation. 2024-7-2

[6]
Interventions to prevent obesity in children aged 12 to 18 years old.

Cochrane Database Syst Rev. 2024-5-20

[7]
Findings from the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[8]
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[9]
Type 2 diabetes mellitus/obesity drugs: A neurodegenerative disorders savior or a bridge too far?

Ageing Res Rev. 2024-7

[10]
An Adaptive Behavioral Intervention for Weight Loss Management: A Randomized Clinical Trial.

JAMA. 2024-7-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索